| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.79e-07 | 11 | 110 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.79e-07 | 11 | 110 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 8.36e-07 | 14 | 110 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.75e-06 | 37 | 110 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.01e-06 | 38 | 110 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.85e-06 | 21 | 110 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | zinc ion binding | CALR TRIM26 CUL9 ZNF407 ERVK-7 ERVK-10 NR3C1 ZCCHC2 LCN1 APOBEC3A TRIM33 ERVK-8 ERVK-19 ZNF84 HERC2 TRIM36 ERVK-11 | 7.36e-06 | 891 | 110 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.78e-05 | 32 | 110 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.00e-05 | 37 | 110 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.57e-05 | 38 | 110 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | VPS18 HECTD3 TRIM26 MAEA CUL9 HUWE1 TRIM33 CCAR1 HERC2 TRIM36 CDC23 | 6.07e-05 | 473 | 110 | 11 | GO:0004842 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.54e-05 | 79 | 110 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.30e-05 | 42 | 110 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.19e-04 | 46 | 110 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | VPS18 HECTD3 TRIM26 MAEA CUL9 HUWE1 TRIM33 CCAR1 HERC2 TRIM36 CDC23 | 1.23e-04 | 512 | 110 | 11 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | VPS18 HECTD3 TRIM26 MAEA CUL9 HUWE1 TRIM33 CCAR1 HERC2 TRIM36 CDC23 | 1.71e-04 | 532 | 110 | 11 | GO:0016755 |
| GeneOntologyMolecularFunction | transition metal ion binding | CALR TRIM26 CUL9 ZNF407 ERVK-7 ERVK-10 NR3C1 ZCCHC2 LCN1 APOBEC3A TRIM33 ERVK-8 ERVK-19 ZNF84 HERC2 TRIM36 ERVK-11 | 2.66e-04 | 1189 | 110 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | acyltransferase activity | VPS18 NAA15 HECTD3 TRIM26 MAEA CUL9 HUWE1 DMAP1 TRIM33 CCAR1 HERC2 TRIM36 CDC23 | 3.39e-04 | 775 | 110 | 13 | GO:0016746 |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 CLTCL1 POTEF INSR ERVK-7 ERVK-10 NEB POTEE KRT222 ERVK-8 ERVK-19 ERVK-25 POTEI POTEJ | 3.84e-04 | 891 | 110 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK2 DOCK3 SH3BP1 RGS11 ANKRD27 KRIT1 ARHGEF9 ARHGEF4 HERC2 ARHGAP21 | 4.94e-04 | 507 | 110 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK2 DOCK3 SH3BP1 RGS11 ANKRD27 KRIT1 ARHGEF9 ARHGEF4 HERC2 ARHGAP21 | 4.94e-04 | 507 | 110 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.24e-04 | 262 | 110 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 9.40e-04 | 136 | 110 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 9.40e-04 | 136 | 110 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.06e-03 | 372 | 110 | 8 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.62e-03 | 398 | 110 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.77e-03 | 231 | 110 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.28e-03 | 100 | 110 | 4 | GO:0019888 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MARS1 CHD9 ERVK-7 MSH4 ERVK-10 DDX11 ZC3H12D PCIF1 ERVK-8 ERVK-11 | 2.98e-03 | 645 | 110 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 3.54e-03 | 113 | 110 | 4 | GO:0019208 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.28e-07 | 13 | 110 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.16e-05 | 31 | 110 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.53e-05 | 35 | 110 | 4 | GO:0099188 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 6.62e-07 | 32 | 110 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 6.62e-07 | 32 | 110 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 2.10e-06 | 18 | 110 | 4 | GO:0000159 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.80e-06 | 45 | 110 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.85e-05 | 104 | 110 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.41e-05 | 109 | 110 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLT1 VPS18 MYO7A POTEF MAEA NEB POTEE DIAPH2 MYH15 POTEI POTEJ ARHGAP21 | 5.16e-05 | 576 | 110 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | actin filament | 1.24e-04 | 146 | 110 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.39e-04 | 94 | 110 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | phosphatase complex | 2.01e-04 | 55 | 110 | 4 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 2.01e-04 | 55 | 110 | 4 | GO:0008287 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | NAA15 MARS1 POTEF MAEA CUL9 AIP DMAP1 POTEE POTEI POTEJ FEM1A USP47 CDC23 | 1.79e-03 | 972 | 110 | 13 | GO:0140535 |
| Domain | PP2A_PR55_CS | 8.72e-10 | 4 | 103 | 4 | IPR018067 | |
| Domain | PP2A_PR55 | 8.72e-10 | 4 | 103 | 4 | IPR000009 | |
| Domain | PR55_2 | 8.72e-10 | 4 | 103 | 4 | PS01025 | |
| Domain | PR55_1 | 8.72e-10 | 4 | 103 | 4 | PS01024 | |
| Domain | Actin_CS | 1.51e-06 | 16 | 103 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 1.96e-06 | 17 | 103 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.52e-06 | 18 | 103 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.17e-06 | 19 | 103 | 4 | PS01132 | |
| Domain | FERM_M | 5.30e-06 | 46 | 103 | 5 | PF00373 | |
| Domain | APC_su10/DOC_dom | 5.61e-06 | 7 | 103 | 3 | IPR004939 | |
| Domain | DOC | 5.61e-06 | 7 | 103 | 3 | PS51284 | |
| Domain | ANAPC10 | 5.61e-06 | 7 | 103 | 3 | PF03256 | |
| Domain | APC10 | 5.61e-06 | 7 | 103 | 3 | SM01337 | |
| Domain | - | 7.27e-06 | 49 | 103 | 5 | 1.20.80.10 | |
| Domain | FERM_central | 7.27e-06 | 49 | 103 | 5 | IPR019748 | |
| Domain | FERM_domain | 7.27e-06 | 49 | 103 | 5 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 8.05e-06 | 50 | 103 | 5 | IPR014352 | |
| Domain | FERM_1 | 8.05e-06 | 50 | 103 | 5 | PS00660 | |
| Domain | FERM_2 | 8.05e-06 | 50 | 103 | 5 | PS00661 | |
| Domain | FERM_3 | 8.05e-06 | 50 | 103 | 5 | PS50057 | |
| Domain | Band_41_domain | 8.05e-06 | 50 | 103 | 5 | IPR019749 | |
| Domain | B41 | 8.05e-06 | 50 | 103 | 5 | SM00295 | |
| Domain | Ankyrin_rpt | 1.46e-05 | 262 | 103 | 9 | IPR002110 | |
| Domain | Actin | 2.45e-05 | 31 | 103 | 4 | IPR004000 | |
| Domain | Actin | 2.45e-05 | 31 | 103 | 4 | PF00022 | |
| Domain | ACTIN | 2.45e-05 | 31 | 103 | 4 | SM00268 | |
| Domain | TPR_REGION | 3.60e-05 | 165 | 103 | 7 | PS50293 | |
| Domain | TPR | 3.60e-05 | 165 | 103 | 7 | PS50005 | |
| Domain | Ank | 3.83e-05 | 228 | 103 | 8 | PF00023 | |
| Domain | - | 6.93e-05 | 248 | 103 | 8 | 1.25.40.20 | |
| Domain | ANK | 7.54e-05 | 251 | 103 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 7.96e-05 | 253 | 103 | 8 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 8.19e-05 | 254 | 103 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 8.19e-05 | 254 | 103 | 8 | PS50297 | |
| Domain | Cul7 | 9.00e-05 | 3 | 103 | 2 | PF11515 | |
| Domain | CPH_domain | 9.00e-05 | 3 | 103 | 2 | IPR021097 | |
| Domain | TPR_repeat | 9.46e-05 | 133 | 103 | 6 | IPR019734 | |
| Domain | - | 1.50e-04 | 207 | 103 | 7 | 1.25.40.10 | |
| Domain | DUF3338 | 1.79e-04 | 4 | 103 | 2 | PF11819 | |
| Domain | DUF3338 | 1.79e-04 | 4 | 103 | 2 | IPR021774 | |
| Domain | TPR-contain_dom | 1.83e-04 | 150 | 103 | 6 | IPR013026 | |
| Domain | Ank_2 | 1.89e-04 | 215 | 103 | 7 | PF12796 | |
| Domain | TPR_8 | 2.08e-04 | 53 | 103 | 4 | PF13181 | |
| Domain | DOCK_N | 2.98e-04 | 5 | 103 | 2 | PF16172 | |
| Domain | DOCK_N | 2.98e-04 | 5 | 103 | 2 | IPR032376 | |
| Domain | TPR-like_helical_dom | 3.08e-04 | 233 | 103 | 7 | IPR011990 | |
| Domain | HECT | 4.33e-04 | 27 | 103 | 3 | PF00632 | |
| Domain | HECTc | 4.33e-04 | 27 | 103 | 3 | SM00119 | |
| Domain | HECT_dom | 4.33e-04 | 27 | 103 | 3 | IPR000569 | |
| Domain | HECT | 4.33e-04 | 27 | 103 | 3 | PS50237 | |
| Domain | ARM-type_fold | 5.78e-04 | 339 | 103 | 8 | IPR016024 | |
| Domain | Clathrin | 6.21e-04 | 7 | 103 | 2 | PF00637 | |
| Domain | TPR_11 | 6.21e-04 | 7 | 103 | 2 | PF13414 | |
| Domain | CHCR | 6.21e-04 | 7 | 103 | 2 | PS50236 | |
| Domain | - | 7.09e-04 | 73 | 103 | 4 | 2.60.120.260 | |
| Domain | FERM_N | 7.88e-04 | 33 | 103 | 3 | IPR018979 | |
| Domain | FERM_N | 7.88e-04 | 33 | 103 | 3 | PF09379 | |
| Domain | Clathrin_H-chain/VPS_repeat | 8.25e-04 | 8 | 103 | 2 | IPR000547 | |
| Domain | SH3 | 1.26e-03 | 216 | 103 | 6 | SM00326 | |
| Domain | SH3 | 1.26e-03 | 216 | 103 | 6 | PS50002 | |
| Domain | SH3_domain | 1.38e-03 | 220 | 103 | 6 | IPR001452 | |
| Domain | DHR-1_domain | 1.60e-03 | 11 | 103 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.60e-03 | 11 | 103 | 2 | PS51651 | |
| Domain | DHR_1 | 1.60e-03 | 11 | 103 | 2 | PS51650 | |
| Domain | DHR-2 | 1.60e-03 | 11 | 103 | 2 | PF06920 | |
| Domain | DOCK | 1.60e-03 | 11 | 103 | 2 | IPR026791 | |
| Domain | DOCK_C | 1.60e-03 | 11 | 103 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 1.60e-03 | 11 | 103 | 2 | PF14429 | |
| Domain | DHR-2 | 1.60e-03 | 11 | 103 | 2 | IPR027357 | |
| Domain | Galactose-bd-like | 1.82e-03 | 94 | 103 | 4 | IPR008979 | |
| Domain | ER_TARGET | 2.21e-03 | 47 | 103 | 3 | PS00014 | |
| Domain | TPR_2 | 2.65e-03 | 50 | 103 | 3 | PF07719 | |
| Domain | TPR_2 | 2.65e-03 | 50 | 103 | 3 | IPR013105 | |
| Domain | Ubiquitin-rel_dom | 3.53e-03 | 184 | 103 | 5 | IPR029071 | |
| Domain | Rib_L2_dom2 | 4.35e-03 | 18 | 103 | 2 | IPR014722 | |
| Domain | - | 4.35e-03 | 18 | 103 | 2 | 2.30.30.30 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 2.29e-06 | 19 | 72 | 4 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 4.27e-06 | 22 | 72 | 4 | M47919 | |
| Pubmed | DOCK3 HLCS CUL9 CHD9 AIP HUWE1 FRMD4B KRIT1 DMAP1 MAPK8IP3 FOCAD TRIM33 CLPB KRT222 CEP70 LRP1 CCAR1 ZNF84 HERC2 ARHGAP21 USP47 | 9.73e-10 | 1285 | 113 | 21 | 35914814 | |
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 3.67e-09 | 7 | 113 | 4 | 25816751 | |
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 15638722 | ||
| Pubmed | 1.31e-08 | 9 | 113 | 4 | 19762425 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.34e-08 | 3 | 113 | 3 | 17101985 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 9514514 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TRIM26 CUL9 AIP HUWE1 NR3C1 ZCCHC2 DDX11 POTEE TRIM33 UNK POTEI POTEJ CDC23 | 6.63e-08 | 588 | 113 | 13 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 EPPK1 CLTCL1 MYO7A MAEA CUL9 FRMD8 HUWE1 SAP30 MAPK8IP3 FOCAD DIAPH2 C19orf44 ARHGEF4 HERC2 FEM1A ARHGAP21 | 1.09e-07 | 1105 | 113 | 17 | 35748872 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.40e-07 | 15 | 113 | 4 | 16824795 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 15578586 | ||
| Pubmed | 3.94e-07 | 19 | 113 | 4 | 32582689 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.94e-07 | 212 | 113 | 8 | 33853758 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.64e-07 | 94 | 113 | 6 | 21542922 | |
| Pubmed | 7.52e-07 | 96 | 113 | 6 | 23580065 | ||
| Pubmed | 1.11e-06 | 56 | 113 | 5 | 22745667 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EOGT MARS1 TRIM26 MAEA INSR CHD9 ATP8B1 HUWE1 MAPK8IP3 PPP2R2A PPP2R2C ARHGEF9 TTC21B LRP1 CCAR1 ZNF84 ARHGEF4 NPAS2 | 1.49e-06 | 1489 | 113 | 18 | 28611215 |
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 16364570 | ||
| Pubmed | 3.66e-06 | 371 | 113 | 9 | 15747579 | ||
| Pubmed | CLTCL1 RAPH1 POTEF SPEF2 UGGT1 RGS11 NEB DDX11 POTEE SCN9A CCAR1 MYH15 ZNF84 ARHGEF4 POTEI POTEJ ARHGAP21 | 4.21e-06 | 1442 | 113 | 17 | 35575683 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.42e-06 | 497 | 113 | 10 | 36774506 | |
| Pubmed | DOCK2 DOCK3 EPPK1 RAPH1 CALR UGGT1 SH3BP1 HUWE1 POTEE ARHGEF9 CCAR1 ARHGEF4 ARHGAP21 | 9.15e-06 | 916 | 113 | 13 | 32203420 | |
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 18971272 | ||
| Pubmed | 9.68e-06 | 149 | 113 | 6 | 22664934 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19759515 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16523501 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24244166 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.05e-05 | 2 | 113 | 2 | 19669888 | |
| Pubmed | Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. | 1.05e-05 | 2 | 113 | 2 | 18447647 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17947714 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17563366 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18697906 | ||
| Pubmed | Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. | 1.05e-05 | 2 | 113 | 2 | 8107808 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9089287 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 1.18e-05 | 14 | 113 | 3 | 9013886 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 1.18e-05 | 14 | 113 | 3 | 27626314 | |
| Pubmed | 1.18e-05 | 14 | 113 | 3 | 9400615 | ||
| Pubmed | 1.18e-05 | 14 | 113 | 3 | 16048649 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 1.48e-05 | 15 | 113 | 3 | 16041367 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.52e-05 | 95 | 113 | 5 | 29643511 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | NAA15 PPP2R2D CALR TRIM26 UGGT1 MAEA AIP HUWE1 KIF7 PPP2R2A CLPB LRP1 USP47 | 1.75e-05 | 974 | 113 | 13 | 28675297 |
| Pubmed | 2.15e-05 | 102 | 113 | 5 | 11214970 | ||
| Pubmed | 2.20e-05 | 17 | 113 | 3 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 2.20e-05 | 17 | 113 | 3 | 21351466 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 2.47e-05 | 105 | 113 | 5 | 19156129 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.61e-05 | 475 | 113 | 9 | 31040226 | |
| Pubmed | 2.63e-05 | 18 | 113 | 3 | 23287597 | ||
| Pubmed | 2.63e-05 | 18 | 113 | 3 | 18664271 | ||
| Pubmed | EXOC6 PPP2R2D UGGT1 HUWE1 ANKRD27 KIF7 PPP2R2A PPP2R2B HERC2 ARHGAP21 | 2.98e-05 | 606 | 113 | 10 | 36538041 | |
| Pubmed | 3.10e-05 | 183 | 113 | 6 | 36129980 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19100874 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 31677785 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 16102737 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 12821648 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 1849734 | ||
| Pubmed | FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth. | 3.13e-05 | 3 | 113 | 2 | 37527040 | |
| Pubmed | CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. | 3.13e-05 | 3 | 113 | 2 | 18722177 | |
| Pubmed | Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. | 3.13e-05 | 3 | 113 | 2 | 18653767 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26868295 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19815552 | ||
| Pubmed | The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth. | 3.13e-05 | 3 | 113 | 2 | 36720499 | |
| Pubmed | 3.97e-05 | 282 | 113 | 7 | 23667531 | ||
| Pubmed | EXOC6 HECTD3 MYO7A NR3C1 NEB KIF7 PPP2R2B GPATCH11 POTEJ USP47 | 4.59e-05 | 638 | 113 | 10 | 31182584 | |
| Pubmed | 4.74e-05 | 513 | 113 | 9 | 25798074 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.25e-05 | 4 | 113 | 2 | 10469592 | |
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 6.25e-05 | 4 | 113 | 2 | 37324936 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 36689403 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 7983737 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 14980518 | ||
| Pubmed | 6.35e-05 | 533 | 113 | 9 | 25544563 | ||
| Pubmed | 8.22e-05 | 26 | 113 | 3 | 11531413 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 9.27e-05 | 223 | 113 | 6 | 33187986 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 29897336 | ||
| Pubmed | iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. | 1.04e-04 | 5 | 113 | 2 | 29897333 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 8812438 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.04e-04 | 5 | 113 | 2 | 12629516 | |
| Pubmed | Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. | 1.04e-04 | 5 | 113 | 2 | 31776290 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 17529992 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CLTCL1 PPP2R2D CALR HLCS DMAP1 PPP2R2A PPP2R2B PPP2R2C POTEI | 1.10e-04 | 573 | 113 | 9 | 28330616 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.23e-04 | 235 | 113 | 6 | 30258100 | |
| Pubmed | 1.56e-04 | 6 | 113 | 2 | 29776906 | ||
| Pubmed | 1.56e-04 | 6 | 113 | 2 | 20220139 | ||
| Pubmed | 1.77e-04 | 251 | 113 | 6 | 29778605 | ||
| Pubmed | 1.84e-04 | 253 | 113 | 6 | 29911972 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.91e-04 | 87 | 113 | 4 | 17148452 | |
| Pubmed | 1.91e-04 | 87 | 113 | 4 | 12465718 | ||
| Pubmed | 2.15e-04 | 493 | 113 | 8 | 15368895 | ||
| Pubmed | 2.17e-04 | 7 | 113 | 2 | 23135275 | ||
| Pubmed | 2.17e-04 | 7 | 113 | 2 | 29419974 | ||
| Pubmed | 2.21e-04 | 36 | 113 | 3 | 22422068 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.37e-04 | 92 | 113 | 4 | 15840729 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 2.47e-04 | 639 | 113 | 9 | 23443559 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 2.71e-04 | 647 | 113 | 9 | 26618866 | |
| Pubmed | HECTD3 ZNF618 HLCS CUL9 CHD9 SAP30 DMAP1 KIF7 TRIM33 PPP2R2A LRP1 CDC23 | 2.83e-04 | 1116 | 113 | 12 | 31753913 | |
| Pubmed | Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. | 2.89e-04 | 8 | 113 | 2 | 12912990 | |
| Pubmed | 2.89e-04 | 8 | 113 | 2 | 11956189 | ||
| Pubmed | Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. | 2.89e-04 | 8 | 113 | 2 | 11007961 | |
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 2.89e-04 | 8 | 113 | 2 | 20080746 | |
| Pubmed | 2.89e-04 | 8 | 113 | 2 | 17245430 | ||
| Pubmed | 2.90e-04 | 653 | 113 | 9 | 22586326 | ||
| Pubmed | 3.25e-04 | 41 | 113 | 3 | 11331580 | ||
| Interaction | SERTAD4 interactions | 4.41e-08 | 19 | 108 | 5 | int:SERTAD4 | |
| Interaction | POTEJ interactions | 3.43e-07 | 52 | 108 | 6 | int:POTEJ | |
| Interaction | IER5 interactions | 5.37e-07 | 13 | 108 | 4 | int:IER5 | |
| Interaction | ACTG2 interactions | 6.36e-06 | 49 | 108 | 5 | int:ACTG2 | |
| Interaction | PABIR1 interactions | 2.20e-05 | 31 | 108 | 4 | int:PABIR1 | |
| Interaction | IER2 interactions | 4.50e-05 | 37 | 108 | 4 | int:IER2 | |
| Interaction | SFTPA2 interactions | 5.00e-05 | 38 | 108 | 4 | int:SFTPA2 | |
| Interaction | SERTAD2 interactions | 5.55e-05 | 39 | 108 | 4 | int:SERTAD2 | |
| Interaction | NEK4 interactions | ZNF487 VPS18 MYO7A POTEF NR3C1 NEB POTEE CLPB TTC21B GPATCH11 HERC2 TRIM36 | 6.72e-05 | 582 | 108 | 12 | int:NEK4 |
| Cytoband | 2q22 | 5.90e-06 | 2 | 112 | 2 | 2q22 | |
| Cytoband | 2q21.1 | 1.29e-05 | 58 | 112 | 4 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 3.64e-05 | 151 | 112 | 5 | chr2q21 | |
| Cytoband | 19p13.3-p13.2 | 5.27e-04 | 14 | 112 | 2 | 19p13.3-p13.2 | |
| Cytoband | 7q21.2 | 6.07e-04 | 15 | 112 | 2 | 7q21.2 | |
| Cytoband | 3p14.1 | 1.57e-03 | 24 | 112 | 2 | 3p14.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.00e-07 | 13 | 76 | 4 | 685 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.80e-07 | 15 | 76 | 4 | 696 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.10e-06 | 50 | 76 | 5 | 1293 | |
| GeneFamily | Ankyrin repeat domain containing | 7.90e-06 | 242 | 76 | 8 | 403 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 3.06e-06 | 166 | 107 | 6 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.45e-06 | 189 | 107 | 6 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-06 | 189 | 107 | 6 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.06e-06 | 192 | 107 | 6 | 522d1bb15edf1d6006b80289bd3baadb99584ae8 | |
| ToppCell | proximal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.06e-06 | 192 | 107 | 6 | f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.06e-06 | 192 | 107 | 6 | 57899a905ca3e336bb7f31edc6418a2546b9891a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.62e-05 | 63 | 107 | 4 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 107 | 5 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.98e-05 | 172 | 107 | 5 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-05 | 172 | 107 | 5 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 6.14e-05 | 173 | 107 | 5 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 175 | 107 | 5 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.60e-05 | 90 | 107 | 4 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-05 | 177 | 107 | 5 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.84e-05 | 177 | 107 | 5 | 066e7500e7bdde88a7914f50a4661d8adf6db925 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.03e-05 | 178 | 107 | 5 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 179 | 107 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.65e-05 | 186 | 107 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.87e-05 | 187 | 107 | 5 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 9.32e-05 | 189 | 107 | 5 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.56e-05 | 190 | 107 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 192 | 107 | 5 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 193 | 107 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 193 | 107 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.03e-04 | 193 | 107 | 5 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-04 | 194 | 107 | 5 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 195 | 107 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 195 | 107 | 5 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-04 | 196 | 107 | 5 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.11e-04 | 196 | 107 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.11e-04 | 196 | 107 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | proximal-Hematologic-Interstitial_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 196 | 107 | 5 | b6a858c43fef42cd724d56c8283e954bcb546106 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 196 | 107 | 5 | 5ed7f063fc4ba213fe15256caf77f59c9e476290 | |
| ToppCell | proximal-3-Hematologic-Interstitial_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 196 | 107 | 5 | d8c9cb86233470c3044865ad05ea202e294d80bf | |
| ToppCell | proximal-Hematologic-Interstitial_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 196 | 107 | 5 | 9d4d8ffe9d30de7d1dc33d261bc2aaf4189ad86c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-04 | 198 | 107 | 5 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 198 | 107 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 198 | 107 | 5 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 198 | 107 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 199 | 107 | 5 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | 713fab2e946b300d21215aff1553785e8857ce65 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 1.19e-04 | 199 | 107 | 5 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 199 | 107 | 5 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 1.19e-04 | 199 | 107 | 5 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.19e-04 | 199 | 107 | 5 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | ffd5b4d58d81b76e01d87016209f16879d81c592 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 200 | 107 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 200 | 107 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 6.52e-08 | 12 | 102 | 4 | DOID:1441 (implicated_via_orthology) | |
| Disease | electroencephalogram measurement | 1.29e-04 | 74 | 102 | 4 | EFO_0004357 | |
| Disease | Schizoaffective Disorder | 1.37e-04 | 29 | 102 | 3 | C0036337 | |
| Disease | Congenital Pain Insensitivity | 2.46e-04 | 7 | 102 | 2 | C0002768 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 3.27e-04 | 8 | 102 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | Ciliopathies | 5.87e-04 | 110 | 102 | 4 | C4277690 | |
| Disease | Pathological accumulation of air in tissues | 7.64e-04 | 12 | 102 | 2 | C0013990 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 7.64e-04 | 12 | 102 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | FLT1 INSR FRMD8 ATP8B1 CYTL1 DDX11 UNK NDUFAF6 USP35 ARHGEF4 | 8.64e-04 | 869 | 102 | 10 | EFO_0004735 |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 1.38e-03 | 16 | 102 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | filaggrin gene expression measurement | 1.38e-03 | 16 | 102 | 2 | EFO_0020899 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.56e-03 | 17 | 102 | 2 | C2936862 | |
| Disease | Abdominal Aortic Aneurysm | 1.71e-03 | 68 | 102 | 3 | EFO_0004214 | |
| Disease | resting heart rate | 1.81e-03 | 149 | 102 | 4 | EFO_0004351 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.95e-03 | 19 | 102 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 2.16e-03 | 20 | 102 | 2 | cv:C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQYSEHCEEAYRVLL | 346 | Q8N6Y0 | |
| YLKAKRYVDSIDICH | 1276 | Q7Z4L5 | |
| YDVIHLKTYDSKRVC | 296 | Q5NDL2 | |
| EECRKELTALLHHYY | 71 | Q969T7 | |
| IETYQVHDYLRSKLC | 316 | Q00005 | |
| VHDYLRSKLCSLYEN | 321 | Q00005 | |
| IETYQVHDYLRSKLC | 316 | Q9Y2T4 | |
| VHDYLRSKLCSLYEN | 321 | Q9Y2T4 | |
| LHYIRKDYEACKAVI | 41 | Q96RK4 | |
| LSYLAHNLCEIDKYR | 316 | Q9UJX2 | |
| LHILYIVCQEYRKTS | 151 | Q8TDN7 | |
| ETYQVHEYLRSKLCS | 321 | P63151 | |
| HEYLRSKLCSLYEND | 326 | P63151 | |
| HCGYLLEKDLEEILY | 936 | Q8IX12 | |
| IGRHKTYLCYEVERL | 26 | P31941 | |
| LEEPSRYIDISKCHY | 521 | Q9H6U8 | |
| RYIDISKCHYLVDLD | 526 | Q9H6U8 | |
| KVEQCRDEYLADLYH | 201 | Q9Y3L3 | |
| ERDYIKHLRDICEGY | 296 | Q9NR80 | |
| VHEYLRSKLCSLYEN | 331 | Q66LE6 | |
| SHYIDIERKLFDETC | 221 | Q8IU99 | |
| LLHFIADICEEKYRD | 876 | O60879 | |
| LYCKGADTVIYERLH | 616 | O43520 | |
| KLVVEEYYEVLDHCS | 241 | O00170 | |
| RHYIKHLKDICEGYL | 116 | O43307 | |
| YIKYLCCDDVRTLHQ | 481 | Q70E73 | |
| GTLVDYEKDCYDRLH | 136 | O94810 | |
| DYYHIDDLELLARCH | 286 | Q99743 | |
| KALVYYDVESCRLDI | 546 | Q96NW4 | |
| EEYHRICELLSDYKE | 466 | A5A3E0 | |
| EHLLRCGYYNTAVKL | 131 | Q7L5Y9 | |
| IYREFERLIHCYDEE | 36 | Q9UPT6 | |
| CTEYHRYIEIAIKQC | 2881 | O95714 | |
| CEAALGTHYRAYLLK | 246 | Q9BZ67 | |
| HEKYLDCQERKLVYV | 61 | Q8N6Y2 | |
| IERCEYDGSHRYVIL | 2401 | Q07954 | |
| CEAALGTHYRAYLLK | 246 | Q9BZ68 | |
| LADCVDIDSYILYHL | 186 | P50747 | |
| HLLEKEEIRYYGCIQ | 141 | Q8N1A0 | |
| TKLIYHTYCERVALV | 176 | A6NMU1 | |
| GTDHYCLELLRKRDY | 56 | Q330K2 | |
| LLDCLVHVSYLEVYK | 136 | Q2M1P5 | |
| YIIHYIDDILCAAET | 191 | P63132 | |
| IIRSHVKDHYIFYCE | 106 | P31025 | |
| REYRAKSYEILLHEV | 26 | O00522 | |
| SELHRLQVSYEEYLC | 651 | P04150 | |
| VSYRRYGDEELHLCV | 886 | P06213 | |
| LEEEHITKIYYCSRT | 221 | Q96FC9 | |
| LYLDIHNYCVLDKLR | 61 | Q9NRR1 | |
| FIYRLEHEVDLCRKE | 456 | Q7Z6Z7 | |
| YIIHYIDDILCAAET | 191 | P63135 | |
| VYRCLHIYSVLGDEE | 286 | Q8TAG9 | |
| EHVYSEKRILEELCS | 496 | Q13237 | |
| RCHSELAFDEFILYK | 141 | Q9H7L2 | |
| YREALEHLCTYEKQI | 206 | Q9BXJ9 | |
| EEYHRICELLSDYKE | 466 | Q6S8J3 | |
| AYCEDRVIEHYKKLN | 181 | Q9P2Q2 | |
| YCEDRVIEHYLKIKG | 221 | Q9Y2L6 | |
| LAYCLVHYRGDEKIK | 1536 | Q3L8U1 | |
| QILTSYLREEHLYCI | 246 | Q8N954 | |
| SDSYVYCLERKSHLL | 136 | Q9NZS2 | |
| CSKIYHISLEYVKRI | 361 | Q9H4Z3 | |
| IRYLYKLRDLHLDCD | 1221 | Q92608 | |
| TTLSDDIHELYVYKC | 536 | Q8IZD9 | |
| KEYVCRGHDYERLEA | 1371 | Q8IZD9 | |
| DHCEALYKEVQRCYL | 86 | Q9UG22 | |
| DELKRLLYDTFCEHL | 131 | Q86V35 | |
| HTVLDRQLLCLIDYY | 206 | Q8NHQ1 | |
| IAKRAHREVDYLFCL | 191 | Q8N5D6 | |
| RSVEDLKERYYHICA | 186 | Q9NPF5 | |
| YHTLEEAKEYIRCHR | 626 | Q9H6X5 | |
| ISCYKGHREIARYLL | 156 | Q9BSK4 | |
| IRCKDDEFTHLYTLI | 161 | P27797 | |
| CRLYGYLIEKNAHES | 236 | Q5I0G3 | |
| YCKLYEHLQRAGSEL | 1501 | Q8IWT3 | |
| HYAVLADDYRTVKEL | 271 | Q9H078 | |
| ITCLERASHYLKTEY | 156 | Q8N8Z6 | |
| ECYRDDHQKLSYKLV | 391 | Q5VW36 | |
| YHGIEYCLDDRKALE | 656 | Q96DY7 | |
| CAVLEAKYLREFHSV | 61 | A6NFF2 | |
| LLKDIHVTSCVYYKE | 231 | Q6ZN16 | |
| RYEKHYSVCAEILDQ | 421 | Q9C093 | |
| CERLLLYLYCHELSI | 966 | Q9UPN9 | |
| KCLYERQVDCSHTLY | 686 | Q9NQ86 | |
| ELDKSARHLYICDYH | 101 | O75446 | |
| LIALYCLKELERSYH | 991 | Q8IVG5 | |
| NAEKLCTLYEERLHE | 1256 | Q9Y2K3 | |
| YRRGCLHKDIYALIS | 2031 | P58107 | |
| YHRICELVSDYKEKQ | 431 | P0CG39 | |
| ECVLKLISLRHYYFT | 1561 | Q15858 | |
| SEIYEHIHCLYKLSD | 601 | O15457 | |
| EEYHRICELVSDYKE | 466 | P0CG38 | |
| ALEHYTDLYDIKRAV | 626 | P53675 | |
| GSCLEDLARKDYHYL | 131 | Q9C0B9 | |
| YIIHYIDDILCAAET | 191 | P63136 | |
| LLLVHERYEQICEFY | 701 | Q5T7W0 | |
| YELHLSVKDYCFARE | 2131 | Q8NB66 | |
| CSEYLKYLLDRLHEE | 521 | Q9P2H5 | |
| RACVHVYKVLELYEE | 711 | Q9P253 | |
| YIIHYIDDILCAAET | 191 | P10266 | |
| YIIHYIDDILCAAET | 191 | P63133 | |
| CRLVKYDEFHDYLER | 656 | Q96K76 | |
| YIIHYIDDILCAAET | 191 | Q9UQG0 | |
| REKLHYYCEDDGKLL | 106 | Q12899 | |
| HGKRLVCYDDRYIVK | 171 | A2A288 | |
| IYHRNRLGEKLYECS | 196 | P51523 | |
| EDTVLDLVDYCHRKL | 131 | O75800 | |
| VREKFSDCYIIHYID | 186 | Q9WJR5 | |
| YLHAGIVSKSYECRL | 1806 | Q9C0G0 | |
| AEEYLHYLSERDACK | 181 | Q2TAA8 | |
| RFTYDHAELERKIAC | 1306 | P17948 | |
| HLRYYKTGICIHETD | 121 | Q9C0B0 | |
| TYKEYIDNRRLHIGC | 391 | Q5T5U3 | |
| EICDKYHIIHADIYR | 331 | P56192 | |
| DFILSHAVYCRDVLK | 871 | Q9NYU2 | |
| YIKEHTRDKTYECNE | 276 | B1APH4 | |
| HYASAKVCEEKLRYA | 831 | Q5T447 | |
| KYLRGYHKCTREEVL | 2021 | Q13402 | |
| AKRCQYILSDLEYRH | 4556 | P20929 |